Supervised Injecting Place Trial Act 1999

The Act organises the trial around a small set of statutory concepts. These should be read as the Act defines them and used to allocate duties, rights and immunities.

• Facility. The facility is the place declared by the Minister in writing under s 5. A declaration is a notifiable instrument and must be given public notice (s 5(1), (3)-(4)). The declaration has preconditions: the place must be hygienic and suitable for providing clean equipment and safe disposal (s 5(2)(a)(i)-(ii)); a law enforcement protocol must have been approved and published (s 5(2)(b)); an internal management protocol must be approved (s 5(2)(c)); approved criteria for the trial must have been presented to the Legislative Assembly (s 5(2)(d)); and the place must have been recommended by the advisory committee (s 5(2)(e)).

• Operator and staff. The Minister declares an operator after consultation with the advisory committee (s 6(1)). If the operator is a non‑government organisation, s 6(2) requires the Minister to act only in accordance with an advisory committee recommendation. Staff of the facility are defined broadly to include the operator, manager, contracted or otherwise engaged persons and volunteers (dictionary). The Act specifies minimum staff qualifications for clinical roles: each member of staff who directly supervises injection must be a doctor or a nurse, and staff who issue injecting equipment must hold an approval under the Public Health Act part 3A (s 9(3)(c)-(d)).

• Law enforcement protocol. The Minister approves, after consultation with the advisory committee, a law enforcement protocol dealing with detection, investigation and prosecution of offences by persons who self‑administer at the facility and anything necessary to give effect to the Act’s object (s 7(1)(a)-(b)). The Act requires the Minister to ensure approval of a protocol that will permit the facility to function according to the Act’s object (s 7(2)) and to publish notice of the protocol’s effect and places where copies may be bought or inspected (s 8).

• Internal management protocol. The Minister may approve an internal management protocol by instrument (s 9(1)). Operators must manage the facility in accordance with it (s 9(2)). Section 9(3) sets out matters the Minister must be satisfied will be met before approving such a protocol: the facility must be under a supervisor; the supervisor must have general oversight of clinical operations; clinical supervisors must be doctors or nurses; syringe‑issuing staff must hold the Public Health Act approval; the facility must contain or provide access to specified health services; staff and users’ health and safety must be protected; advisory committee recommendations must be given effect; and regulations must be complied with (s 9(3)(a)-(h)).

• Criteria and evaluation. The Act requires consultation with the advisory committee on criteria for assessing the scientific trial (s 10), including an attempt to agree. Approved criteria and any alternative criteria or the Minister’s reasons must be presented to the Assembly within three sitting days (s 10(4)). The advisory committee must report every six months and arrange an assessment of the trial against the approved criteria before the Act expires (s 31).

• Legal immunities and authorisations. The Act authorises staff to supply sterile equipment at the facility despite other Territory laws (s 15) provided return for safe disposal is agreed and counselling etc is offered in many circumstances (s 15(a)-(b)). It provides a conditional criminal‑law exemption for Ministers, public employees, staff and premises owners/occupiers for acts done in good faith and in capacity and in accordance with regulatory requirements (s 11). It also provides a broad civil indemnity and bar to civil proceedings against the Territory or anyone else for harm caused by self‑administration or related acts by the user (s 12). Separately, s 13 obliges the Attorney‑General to give directions to the DPP to avoid deterring users by fear of prosecution and identifies specific offences to which restraint should apply.

• Time limit and regulation. The scheme is temporary: the Act expires two years after the first declaration (s 33). The Executive may make regulations to give effect to the Act (s 32), including prescribed requirements referenced in s 11 and s 9(3)(h).

Each of these concepts interacts through procedural gates: declarations (s 5), approvals (s 7, s 9), consultation and recommendations (s 6, s 10, s 29), publication (s 5(3)-(4), s 8), and reporting (s 31). The Act uses defined descriptors from its dictionary (for example staff, substance, supervised injecting place), so reading those definitions together with the substantive sections is necessary for correct legal application.

The Act creates legal effects that touch a defined list of public and private actors. The following parties have direct and immediate roles, responsibilities or potential exemptions under the statute.

• The Minister. The Minister has core decision‑making authority: declaring the facility (s 5), declaring an operator after consulting the advisory committee (s 6), approving law enforcement and internal management protocols (s 7-9), presenting criteria to the Legislative Assembly (s 10(4)), appointing advisory committee members and chair/deputy (s 20-21), receiving reports and, where the Minister refuses to accept advisory committee recommendations, providing written reasons to the chair and the Assembly (s 29(2)). The Minister therefore decides on location, operator choice (subject to advisory committee recommendation when the operator is an NGO), and operational conditions.

• Advisory committee members and nominating organisations. Section 20 specifies the advisory committee’s constitution, including ex officio and nominated representatives: director‑general, the Australian Federal Police, the director of public prosecutions, legal aid, ambulance service, Australian Institute of Criminology, Australian Medical Association, a business association, WIREDD, residents’ association, various drug and health organisations, Aboriginal health service, Youth Coalition, and others. These members make recommendations to the Minister and have a statutory role in criteria-setting, site recommendation, and periodic reporting (s 19, s 29-31).

• Operator and staff. The operator is declared by the Minister after consultation (s 6). Staff categories are defined and include paid and volunteer roles (dictionary). The operator must manage the facility in accordance with the internal management protocol and the Act’s requirements (s 9(2)-(3)). Clinical supervisors must be doctors or nurses and syringe‑issuing staff must hold an approval under the Public Health Act part 3A (s 9(3)(c)-(d)). Staff have a contingent criminal exemption under s 11 if acts are in good faith, in capacity, and comply with prescribed regulatory requirements.

• Drug‑dependent people and users. The Act is expressly designed to enable access by drug‑dependent people to a supervised and hygienic environment to self‑administer substances and to obtain clean equipment and referral to health services (s 4, dictionary). Users are subject to operational restrictions: they must return equipment for safe disposal (s 15(a)); they may not possess more than 0.5 g in the facility (s 14(c)); they may not possess substances outside the facility (s 14(d)); and they may be excluded from the facility for up to three days or longer by written notice (s 17).

• Owners and occupiers of premises. Owners and occupiers where the facility is sited are explicitly included in the criminal exemption class in s 11, subject to the good faith, capacity and regulation requirements. They are also potential targets of advisory committee consideration when recommending a site (s 30 refers to capacity to maintain hygiene and disposal).

• Director of Public Prosecutions and Attorney‑General. The Attorney‑General must direct the DPP under the DPP Act to ensure potential users are not deterred by fear of prosecution, and those directions must include restraint in specified circumstances (s 13). The DPP is therefore an addressee of explicit statutory directions designed to shape prosecutorial discretion in relation to the trial.

• Legislative Assembly. The Assembly is a recipient of materials and oversight: approved criteria and any alternative criteria and Minister’s reasons must be presented within prescribed timeframes (s 10(4)); advisory committee reports must be presented after receipt (s 31(3)); and if the Minister rejects committee recommendations, the Minister must present a written statement of reasons to the Assembly (s 29(2)(b)).

• Public health and regulatory bodies. The Act cross‑references the Public Health Act (s 9(3)(d)) and other Territory laws it displaces in limited respects (s 15, s 16), so administrative agencies charged with implementing disease prevention, syringe supply approvals and other public health functions are implicated.

Who pays is not specified in the Act. The Act confers the power to create a facility and to approve protocols but it does not set out appropriation or funding mechanisms. Consequently, funding and resourcing decisions are left to the Executive, the Minister and any operator arrangements established outside the Act. The Act affects private entities such as potential NGO operators and owners whose premises will be used, but it does not itself allocate direct funding obligations.

The Act establishes a set of discrete statutory duties and corresponding rights for the principal participants. These duties are procedural, operational, and supervisory in nature. Below are the principal duties and rights with section references.

Duties of the Minister and Executive

• Declare the facility only where statutory preconditions are satisfied: hygienic suitability, approved and published law enforcement protocol, approved internal management protocol, presentation of approved criteria to the Assembly, and advisory committee recommendation (s 5(2)(a)-(e)). Declarations are notifiable instruments and require additional public notice (s 5(3)-(4)).
• Consult the advisory committee about site, operation hours, access conditions, terms for under‑18s, and evaluation criteria (s 29(1)). If the Minister does not follow the committee recommendation, the Minister must provide written reasons to the chair within 14 days and present a copy to the Assembly within three sitting days (s 29(2)(a)-(b)).
• Approve a law enforcement protocol after consultation (s 7(1)), ensure the protocol will allow the facility to function in accordance with the object (s 7(2)), and publish notice of its effect and places where copies can be inspected or bought (s 8(1)-(3)).
• Approve an internal management protocol only after being satisfied that specified operational and clinical requirements will be met, including supervisor oversight, clinical staffing, access to an enumerated set of health services, staff health and safety protections, and compliance with any regulations (s 9(1)-(3)(a)-(h)).
• Present approved criteria, together with alternative criteria and the Minister’s reasons where applicable, to the Legislative Assembly within three sitting days after approval (s 10(4)).
• Direct the DPP under the DPP Act to ensure people are not deterred by fear of prosecution and include directions restraining prosecution for certain named offences (s 13(1)-(2)).

Duties of the operator and staff

• Operate and manage the facility in accordance with the internal management protocol approved by the Minister (s 9(2)).
• Ensure staff who directly supervise injections are doctors or nurses (s 9(3)(c)), and that staff issuing injecting equipment hold the Public Health Act approval (s 9(3)(d)).
• Offer counselling, rehabilitation or medical services before issuing equipment to a person unless the staff member knows or reasonably believes the person has already administered a substance (s 15(b)).
• Require users to agree to return injecting equipment after use for safe disposal (s 15(a)).
• Remove and exclude persons from the facility by oral direction for up to three days, or by written notice with brief reasons, and enforce exclusion with a penalty of up to 10 penalty units for re‑entry during the exclusion period (s 17(1)-(3)).

Rights and immunities

• Lawful provision of sterile injecting equipment at the facility by staff despite any other Territory law (s 15).
• Authorities and specified persons may lawfully give information about the operation of the facility to specified recipients (Legislative Assembly, Minister, advisory committee, and a Minister‑appointed reviewer) despite other Territory laws (s 16).
• Conditional criminal exemption for Ministers, public employees, facility staff, and premises owner/occupier for acts done in good faith, in capacity, and in accordance with requirements prescribed under the regulations (s 11(1)-(2)). The exemption covers criminal proceedings, including accessory after the fact (s 11(2) referencing Criminal Code s 717).
• A broad civil defence: no civil proceeding lies against the Territory or anyone else in relation to death, loss or injury caused by or arising out of self‑administration at the facility or related acts by the affected person (s 12).

Express prohibitions and limits

• The Act expressly does not permit staff to sell, possess or use substances in the facility, does not permit users to sell or supply substances in the facility, limits possession to 0.5 g within the facility, and does not permit possession outside the facility (s 14(a)-(d)). These operational constraints remain enforceable notwithstanding the trial allowances.

Reporting and oversight duties

• The advisory committee must report to the Minister on facility operation and the committee’s views every six months and must arrange an assessment of the trial against approved criteria before expiry (s 31(1)-(2)). The Minister must present these reports to the Assembly within six sitting days of receipt (s 31(3)).

Regulatory and procedural duties

• The Executive may make regulations (s 32), and the Act references requirements “prescribed under the regulations” as conditions to the criminal exemption in s 11(2)(c). That means duties may be further specified by regulation.

Taken together, these duties create a structured chain of decision‑making: advisory committee recommendations feed into Ministerial approvals (s 5, s 6, s 10), approvals and protocols constrain operator obligations (s 9(2)), operators and staff must comply with clinical and public health standards (s 9(3), s 15), and the Attorney‑General and DPP must implement prosecutorial directions in support of the trial (s 13). Rights and immunities are conditional and linked to good faith, capacity and compliance with any prescribed requirements.

The Act uses a mix of administrative, prosecutorial and civil provisions to manage compliance, together with a limited penalty for breach of certain operational exclusions. Enforcement mechanisms are distributed among the Minister, the DPP, law enforcement agencies, the operator, and the courts subject to statutory immunities.

Penalties

• Exclusion breach. Section 17(3) establishes a specific criminal penalty for a person who, after being excluded under s 17(1) or (2), fails to leave the facility or re‑enters during the exclusion period: maximum 10 penalty units. The republication preface states the penalty unit value as at 1 September 2016 ($150 for an individual and $750 for a corporation), noting that the value is determined by the Legislation Act (see republication preface). The Act itself records the quantum in penalty units rather than a monetary value (s 17(3)).

Other offences and enforcement constraints

• The Act expressly preserves certain criminal offences by preventing the Minister from approving a law enforcement protocol that has the effect of exempting facility staff from the operation of a law in relation to possession, use or dealing in substances (s 7(3)). That means protocol design cannot create blanket decriminalisation for staff; instead, the Act relies on prosecutorial direction (s 13) and statutory exemptions in narrowly defined circumstances (s 11).

• The Attorney‑General must give directions to the DPP designed to ensure people are not deterred by fear of prosecution, and those directions must identify circumstances when the DPP is restrained from prosecuting persons administering a substance at the facility for specific offences under the Drugs of Dependence Act 1989 and the Medicines, Poisons and Therapeutic Goods Act 2008 (s 13(1)-(2)). The DPP’s exercise of prosecutorial discretion will be shaped by those directions, but the Act contemplates the DPP continuing to have a prosecutorial role subject to statutory directions.

• The criminal exemption in s 11 applies to particular categories of persons where specified conditions are met (s 11(1)-(2)). That exemption removes the viability of certain prosecutions against those persons for conduct done in good faith, in capacity, and in accordance with requirements prescribed under the regulations. The exemption applies also to offences including accessory after the fact under the Criminal Code (s 11(2) explicitly includes reference to Criminal Code s 717).

Civil immunity

• Section 12 provides a statutory bar to civil proceedings against the Territory or anyone else in relation to death, or any loss or injury caused by or arising out of self‑administration at the facility, or anything done by the affected person in relation to the self‑administration. This is an unusually broad civil immunity provision; it operates to remove tort claims that otherwise might be available against a range of potential defendants, including the Territory, staff, operators or owners. The operation of s 12 will be a primary determinant of civil exposure.

Administrative enforcement and oversight

• The law enforcement protocol approved by the Minister is intended to govern how police detect, investigate and prosecute offences connected with the facility, and the Minister must publish the effect of that instrument and ensure copies are publicly accessible (s 7-8). This creates an administrative process and public transparency requirement intended to shape on‑the‑ground enforcement activity.

• Internal management protocol compliance is an operational obligation on the operator (s 9(2)) and the Minister must be satisfied that defined staff and service standards will be met before approving such a protocol (s 9(3)). Non‑compliance with an approved internal management protocol would fall to administrative oversight, potentially resulting in withdrawal of approval or other Executive actions, though the Act does not specify a bespoke enforcement sanction for internal protocol breach.

Limits and interaction

• The Act expressly disapplies other Territory laws for specific acts: s 15 and s 16 both say “Despite any other provision of this Act or of another Territory law, it is lawful for…” which creates a statutory carve‑out for provision of injecting equipment at the facility and for provision of information about the facility. Those carve‑outs are narrow and conditionally expressed.

• Importantly, the Act both creates immunities and preserves prosecutorial discretion: while s 11 and s 12 limit criminal and civil exposure in specified circumstances, s 7(3) prevents approval of a law enforcement protocol that would exempt staff from the operation of drug laws. The DPP directions required under s 13 are a tool for managing prosecutions but do not abolish prosecutorial authority; they instead constrain it in ways the Attorney‑General specifies.

Practical enforcement picture

• On the ground, enforcement will be a hybrid: police and prosecutorial policy will operate according to the published law enforcement protocol and DPP directions, operators will implement internal management protocol obligations and exclusion powers, staff and specified persons will rely on the conditional exemptions, and civil exposure will be limited by s 12. The Act creates specific enforcement powers (exclusion and penalty for breach) and leaves other enforcement choices to existing instruments (police action, DPP decisions), but it binds those choices to processes of publication and Ministerial oversight.

The Act is drafted to sit alongside and, in narrowly drawn respects, override or modify the operation of other Territory statutes. It cross‑references specific legislative instruments and establishes conditional carve‑outs for conflictual laws.

Express cross‑references and dependencies

• Public Health Act 1997. Section 9(3)(d) requires that any member of staff who issues equipment for injection at the facility must hold an approval under the Public Health Act 1997, part 3A (Supply of syringes). That means a statutory approval regime external to this Act governs who may issue syringes at the facility. The Act therefore depends on an existing public health regulatory regime for at least one operational element.

• Drugs of Dependence Act 1989 and Medicines, Poisons and Therapeutic Goods Act 2008. Section 13(2) identifies specific offences under the Drugs of Dependence Act 1989 (s 169 Possessing drugs of dependence, s 171 Possessing prohibited substances) and the Medicines, Poisons and Therapeutic Goods Act 2008 (s 36 Possessing certain declared substances, s 37 Administering certain declared substances) as offences for which the DPP must be given directions restraining prosecution in specified circumstances. The Act therefore interacts directly with territorial criminal and regulatory medicine/poisons provisions by requiring prosecutorial policy responses.

• Criminal Code. Section 11(2) references Criminal Code s 717 (Accessory after the fact) when describing the scope of criminal proceedings that do not lie against persons covered by the criminal exemption. Hence the exemption may extend to complicity‑type charges under the Code, subject to conditions.

• Director of Public Prosecutions Act 1990. Section 13(1) directs the Attorney‑General to give directions to the DPP under the Director of Public Prosecutions Act 1990, s 20(1). The DPP Act provides the legal vehicle for binding prosecutorial directions; the Act prescribes the content requirement for those directions.

Override or carve‑outs

• Section 15: Despite any other provision of this Act or of another Territory law, it is lawful for facility staff to provide sterile equipment at the facility provided return for disposal and prior offering of counselling etc. This is an explicit statutory override of any Territory provision that would otherwise criminalise or prohibit such supply in the facility.

• Section 16: Similarly, s 16 says that despite any other provision of this Act or another Territory law, persons may give information about the operation of the facility to the Legislative Assembly, Minister, advisory committee, or a Minister‑appointed reviewer. This creates a protected channel for information flow that might otherwise be constrained by confidentiality provisions in other statutes.

• Section 11 criminal exemption: The Act creates a rule that criminal proceedings do not lie against specified persons for acts done in good faith in capacity and under regulatory requirements. That displaces criminal liability in particular circumstances and collides with the general application of criminal law unless narrowly construed by courts; but s 7(3) circumscribes the Minister’s ability to exclude staff from the operation of drug laws via the law enforcement protocol.

Civil law interaction

• Section 12 provides an express bar to civil proceedings against the Territory or anyone else in relation to death or loss/injury caused by or arising out of self‑administration at the facility or related acts by the affected person. This is a direct displacement of ordinary civil remedies that would otherwise exist under tort law. The Act does not expressly list exceptions to that bar; therefore the statutory bar will apply as written unless other laws or constitutional constraints require reconciliation.

Regulatory gap and delegation

• The Act grants regulation‑making power to the Executive (s 32) and makes particular obligations contingent on “requirements prescribed under the regulations” (s 11(2)(c)). That means some details of compliance, criminal exemption scope, and possibly record‑keeping or other procedural requirements will be set out in regulations, creating a secondary layer of law that must be considered in operation.

Procedural interactions with the Legislative Assembly

• The Act compels the Minister to present approved criteria and the advisory committee’s alternative criteria or Minister’s reasons to the Legislative Assembly (s 10(4)), and requires the Minister to present advisory committee reports within prescribed timeframes (s 31(3)). Those parliamentary interactions create transparency obligations that interface with the Assembly’s legislative and oversight functions.

Limitations and preserved application

• Section 7(3) states the Minister must not approve a law enforcement protocol that exempts facility staff from the operation of a law in relation to possession, use or dealing in substances. That keeps the core criminal law framework intact and prevents the Act being used to authorise wholesale legal immunity via administrative instrument. In other words, operational carve‑outs are tightly controlled and require either prosecutorial directions (s 13) or carefully drafted statutory exemptions (s 11), rather than delegation to a law enforcement protocol to effect decriminalisation.

Unspecified funding and administrative interplay

• The Act does not allocate funding or appropriations and therefore interacts with general administrative law and public sector funding arrangements. The lack of explicit funding provisions means the Executive and relevant agencies must resolve resourcing and service provision through existing budgetary mechanisms, contracts with operators, or other administrative arrangements outside the Act.

In sum, the Act creates narrowly targeted statutory modifications to other Territory laws (s 15, s 16, s 11, s 12) and an obligation on prosecutorial authorities to adopt policies to reduce deterrence (s 13). Key operational elements depend on external laws such as the Public Health Act for syringe supply approval. Regulations under s 32 are likely to flesh out detail and thereby further interact with the existing legal framework.

The Act’s text and structure in the republication reflect a series of legislative amendments over time. The endnotes record the principal amending Acts and the sections they altered. Below is a source‑grounded summary of those amendments as set out in the legislation history and amendment history endnotes.

• Supervised Injecting Place Trial Act 1999 (A1999‑90) , original enactment. Notified 23 December 1999, commenced 23 December 1999. The Act contains an expiry clause: it expires two years after the day when the first declaration is made under s 5 (s 33).

• Supervised Injecting Place Trial Amendment Act 2000 (A2000‑39). Notified 12 July 2000; commenced 12 July 2000. The amendment history records s 5 being amended by A2000‑39 (see amendment history entries).

• Legislation (Consequential Amendments) Act 2001 (A2001‑44) , multiple technical amendments affecting appointment provisions, declaration processes and regulation‑making references; commencement varied across parts (some provisions commenced 12 September 2001). Notably, s 6 (Declaration of operators), s 7 and s 32 were amended (see amendment history entries).

• Statute Law Amendment Act 2003 (No 2) (A2003‑56) , amendments to a range of sections and movement of definitions into the dictionary; renumbering/relocations of definitions and removal of certain obsolete references. Several sections including s 9 (internal management protocol), s 19 (committee functions), and s 20 (constitution) were amended or had material relocations. Some appointment and procedural changes were effected (see amendment history and the dictionary entries).

• Emergencies Act 2004 (A2004‑28) , an amendment to the dictionary is noted in the amendment history.

• Medicines, Poisons and Therapeutic Goods Act 2008 (A2008‑26) , this Act prompted consequential amendments in the Supervised Injecting Place Trial Act: for example the long title, s 9, s 10, s 14, and the dictionary were amended to reflect the contemporary statutory references to “substance” and to adjust cross‑references to medicines/poisons provisions (see amendment history entries referencing A2008‑26).

• Statute Law Amendment Act 2008 (A2008‑28) , further amendments affecting some sections, including s 11 and s 22 (ending appointments) (see amendment history).

• Statute Law Amendment Act 2009 (No 2) (A2009‑49) , amendments further refining appointment termination grounds and dictionary entries (see amendment history).

• Administrative (One ACT Public Service Miscellaneous Amendments) Act 2011 (A2011‑22) , amendments affecting administrative arrangements, notably s 28 (administration) and dictionary entries to reflect updated public service structures (see amendment history).

• Red Tape Reduction Legislation Amendment Act 2015 (A2015‑33) , amendments including to s 5 and s 8 (publication obligations) to remove or update certain references and to streamline notification procedures (see amendment history).

• Public Sector Management Amendment Act 2016 (A2016‑52) , amendments recorded in the legislation history; some changes commenced 1 September 2016.

The amendment history endnote (4) lists particular sections affected by each amending Act (for example: s 5 amended by A2000‑39, A2001‑44, A2003‑56, A2008‑26, A2015‑33). The dictionary saw multiple insertions, substitutions and relocations across the amendments, reflecting consolidations and changes to definitions and cross‑references (see amendment history, dictionary entries). The republication notes that editorial changes under the Legislation Act 2001, part 11.3 may have been made but do not affect substance and are not annotated here.

Readers should consult the endnotes for precise amendment instruments and the amendment history table because the Act’s current operation is the result of successive statutory adjustments, including relocation of definitions and cross‑references to other Acts. The Act as republished on 1 September 2016 includes amendments up to A2016‑52. The expiry mechanism (s 33) remains a core structural element: the Act is temporary and its operative window is triggered by the first declaration under s 5.

The text of the Act and its republication endnotes do not cite any judicial decisions or litigation history concerning the Supervised Injecting Place Trial Act 1999. There are no cases named in the statute or in the endnotes. Therefore, the document contains no recorded litigation history for the Act itself as of the republication date.

That absence of recorded litigation in the source does not eliminate the potential for legal proceedings to arise from the Act’s content. The Act contains multiple provisions that can be expected to generate interpretive questions or factual disputes likely to engage courts or tribunals if contested. These potential points of legal contest are set out below, with references to the statutory provisions that create the potential for litigation or administrative review.

• Scope and meaning of the criminal exemption in s 11. The exemption applies where conduct is “done in good faith by the person in the person’s capacity as a person to whom this section applies” and “done in accordance with the requirements (if any) prescribed under the regulations” (s 11(2)(a)-(c)). Litigation could arise over the statutory meaning of “good faith”, what acts fall “in the person’s capacity”, and compliance with any regulatory requirements once regulations are promulgated. Interpretation of these phrases typically turns on statutory construction and factually specific evidence; courts could be asked to determine whether the conditions for immunity are met in particular circumstances.

• Interaction between s 11 criminal exemption and s 7(3) prohibition on protocols exempting staff from offences. Section 7(3) prohibits the Minister approving a law enforcement protocol that exempts staff from drug law operation; s 11 creates a statutory exemption under conditions. A legal dispute could test whether a particular act of the Minister, prosecutor or police is consistent with both provisions. Courts may be asked to resolve whether prosecutorial restraint (s 13) or regulatory requirements effectively create an immunity that conflicts with s 7(3).

• Breadth and application of the civil bar in s 12. Section 12 states “A civil proceeding does not lie against the Territory or anyone else in relation to the death of, or any loss or injury sustained by, someone (the affected person) caused by, or arising out of…self‑administration by the affected person of a substance at the facility; or…anything else done by the affected person…in relation to the self‑administration.” The broad language could raise litigation on whether particular claims (for example claims in negligence against an operator or staff) are encompassed, whether there are implied exceptions, or how the bar interacts with other statutory duties. Courts would be required to take the statutory language as the starting point.

• Validity and limits of DPP directions in s 13. Section 13 mandates Attorney‑General directions to the DPP under the Director of Public Prosecutions Act 1990, s 20. Litigation may occur if a person sought to challenge the content or lawfulness of DPP directives, or if the DPP declined to follow directions in particular circumstances. Questions could also arise about the binding nature of such directions and their scope vis‑à‑vis prosecutorial independence as set in the DPP Act, requiring judicial interpretation of interlocking statutory duties.

• Constitutional and administrative law challenges to the Act’s immunities and procedural steps. Parties could test whether certain immunities are compatible with other legal obligations or with public law requirements, for example in relation to procedural fairness where an operator’s approval is withdrawn, or in disputes over Ministerial decisions that are alleged to be procedurally unfair. The Act’s requirement that the Minister present reasons if rejecting advisory committee recommendations (s 29(2)) creates an administrative check, but disputes over adequacy of reasons could arise.

• External statutory interplay. Litigation may arise to clarify the relationship between this Act and other statutes referenced in it , for example the Public Health Act (s 9(3)(d) reference), Drugs of Dependence Act 1989 and Medicines, Poisons and Therapeutic Goods Act 2008 (s 13(2) references), and the Criminal Code (s 11(2) referencing s 717). Courts may be asked to construe which provisions prevail in particular factual contexts.

Because the republication contains no reported decisions, the actual litigation contours are hypothetical based on statutory wording. The Act’s express bars and immunities, coupled with retained prosecutorial and criminal law instruments, create legal fault lines that would likely be litigated if contested factual scenarios arose. Practitioners should therefore anticipate interpretive disputes on the meaning of “good faith”, the scope of the civil bar in s 12, the limits of Ministerial and prosecutorial instruments, and compliance with regulatory requirements that the Executive may later prescribe.

Several provisions of the Act present practical or legal pitfalls that can trap actors who assume broader protections or easier implementation than the text allows. The following items are concrete operational, compliance and legal “gotchas” grounded in the Act’s wording.

1. Temporariness: the Act expires two years after the first declaration (s 33). If the Minister makes the first declaration, the clock starts running. There is no automatic continuation or extension clause in the Act itself; consequences for continuity of services, long‑term contracts, research timelines and staff arrangements must be handled outside the Act or via subsequent legislation.

2. Conditional immunities. Criminal exemption for staff, ministers, public employees and premises owners is conditional: acts must be done in good faith, in capacity, and in accordance with requirements prescribed under the regulations (s 11(2)). Until the Executive prescribes those regulations under s 32, the precise regulatory conditions that determine immunity are unknown. Parties should not assume immunity simply because they are staff or an owner.

3. Ministerial limit on NGO appointment. Section 6(2) states the Minister shall not declare a non‑government organisation to be the operator other than in accordance with a recommendation of the advisory committee. If stakeholders expect Ministerial discretion to appoint a preferred NGO operator without committee endorsement, they will be surprised by this constraint. The advisory committee therefore has meaningful gatekeeping power over NGO operators.

4. Law enforcement protocol cannot exempt staff from drug laws. Section 7(3) forbids the Minister from approving a law enforcement protocol that has the effect of exempting facility staff from the operation of laws in relation to possession, use or dealing. That means immunity for staff cannot be achieved simply by drafting a permissive protocol; s 11 statutory exemptions or DPP directions (s 13) must be used instead. Reliance solely on the law enforcement protocol for staff protection is a legal pitfall.

5. Mandatory clinical staffing and approvals. The internal management protocol approval requires that each member of staff directly supervising injections be a doctor or a nurse and that staff issuing equipment must hold an approval under the Public Health Act part 3A (s 9(3)(c)-(d)). If recruitment or volunteer models do not meet these requirements, the Minister must not approve the internal management protocol, and the facility cannot lawfully operate under this Act.

6. Narrow “lawful” supply of equipment conditions. Section 15 permits staff to provide sterile equipment despite other laws, but only where the recipient agrees to return the equipment after use and, unless the staff member knows or reasonably believes the person has administered previously, the recipient has been offered counselling, rehabilitation or medical services. Practically, this obliges staff to offer services and record offers; failure to do so may undermine the “despite any other law” protection and invite external enforcement action.

7. Possession limits and external exposure. Section 14(c) caps possession in the facility at 0.5 g and forbids possession outside the facility (s 14(d)). Users leaving the facility in possession of substances risk prosecution under other laws. Operators and staff must actively manage user behaviour and disposal to avoid contraventions, but the Act does not displace private possession laws outside the narrow facility context.

8. Broad civil bar. Section 12 says no civil proceeding lies against the Territory or anyone else in relation to harm caused by or arising out of self‑administration at the facility. Operators, staff and owners may interpret this as complete civil immunity, but the precise scope and potential exceptions (such as wilful misconduct or other public law claims) could be litigated. Parties should not rely on the bar as absolute legal insulation without legal advice.

9. Publication and accessibility obligations. The Minister must give public notice of the law enforcement protocol’s effect and state places where copies may be bought or inspected (s 8). Failure to ensure availability and inspection rights could render the protocol non‑compliant with s 8(2)-(3) and invite challenges to its validity or the facility’s ability to rely on it.

10. Reporting and timelines. The advisory committee must report every six months and produce an assessment before expiry (s 31). The Minister must present reports to the Legislative Assembly within six sitting days (s 31(3)), and approved criteria must be presented within three sitting days (s 10(4)). Administrative or timing failures could create political and legal friction and could be relied upon in judicial or parliamentary scrutiny.

11. DPP directions are not self‑executing. Section 13 requires the Attorney‑General to give directions to the DPP under the DPP Act s 20(1). The effectiveness of those directions depends on the content and whether the DPP adopts them. Parties should assume prosecutorial discretion remains a live factor and that the DPP’s interpretation of directions may be operationally significant.

12. Undefined funding. The Act does not specify who funds setup, ongoing operation, staff remuneration, medical services or the independent evaluation. Parties acting on the assumption that Government funding is guaranteed may face contractual and financial risk. Lack of funding detail is a material operational “gotcha”.

13. Regulatory uncertainty. Several important aspects are “subject to the regulations” (s 11(2)(c); s 9(3)(h) refers to any regulations concerning operation). Until regulations are made under s 32, the precise compliance standards, record‑keeping obligations, or other requirements that underpin immunities and approvals are uncertain.

14. Exclusion sanctions and user management. The operator’s power to exclude is capped in duration for oral exclusions (three days) but may be longer if in writing (s 17(1)-(2)). The maximum penalty for re‑entry while excluded (10 penalty units) is specific. Operators must comply with procedural requirements when excluding people; failing to provide proper written reasons could raise fairness or administrative law concerns.

Being mindful of these “gotchas” and building operational plans that account for them is essential. The Act provides significant authorities and limited immunities, but they are tightly conditional and rely on parallel instruments (regulations, DPP directions, Public Health Act approvals) and administrative compliance.

This section sets out concrete, source‑grounded steps and checklists for the principal actors , Minister/Executive, advisory committee, operator, staff, and the Attorney‑General/DPP , to comply with the Act’s textual requirements. Each task cites the relevant statutory provision.

For the Minister and Executive

• Prepare criteria for the scientific trial in consultation with the advisory committee and attempt to reach agreement (s 10(1)). If agreement is reached, approve them; if not, obtain the advisory committee’s alternative criteria and approve a set with written reasons for departing from alternatives (s 10(2)-(3)). Present the approved criteria and any alternative criteria with Minister’s reasons to the Legislative Assembly within three sitting days (s 10(4)).

• Before declaring a place to be the facility, ensure all statutory preconditions are satisfied: (a) the place is a hygienic environment suitable for provision of clean equipment and safe disposal (s 5(2)(a)); (b) a law enforcement protocol has been approved and is to be published (s 5(2)(b), s 7-8); (c) an internal management protocol has been approved (s 5(2)(c), s 9); (d) approved criteria have been presented to the Assembly (s 5(2)(d), s 10(4)); and (e) the place has been recommended by the advisory committee (s 5(2)(e)).

• Draft, approve and publish a law enforcement protocol after consulting the advisory committee (s 7(1)). Ensure the protocol does not purport to exempt staff from the operation of drug laws (s 7(3)). Publish notice of the protocol’s effect as soon as practicable, stating where copies may be bought or inspected and ensure those copies are available at stated locations (s 8(1)-(3)).

• Approve an internal management protocol by instrument only after being satisfied the requirements in s 9(3) will be met: supervisor oversight, clinical supervision by doctors/nurses, approvals under the Public Health Act for syringe‑issuing staff, access to listed health services, health and safety protections, effecting advisory committee recommendations, and compliance with regulations (s 9(3)(a)-(h)). Ensure the operator understands and agrees to manage strictly in accordance with the approved protocol (s 9(2)).

• If rejecting any advisory committee recommendation on matters in s 29(1), provide a written statement of reasons to the chair within 14 days and present a copy to the Legislative Assembly within three sitting days (s 29(2)(a)-(b)).

• Make the declaration of facility a notifiable instrument and give the additional public notice required (s 5(3)-(4)).

For the Attorney‑General and the DPP

• Give directions to the DPP under the Director of Public Prosecutions Act 1990, s 20(1) as required by s 13(1) to ensure people are not deterred by fear of prosecution. The directions must include circumstances where the DPP is restrained from prosecuting a person who administers a substance at the facility for the specified offences identified in s 13(2). Document and publish relevant guidance consistent with the law enforcement protocol and s 8 publication obligations.

For the advisory committee

• Make written recommendations to the Minister on location, operation, access conditions, under‑18 terms and evaluation criteria (s 19, s 29(1)). Set out preferred criteria where agreement with the Minister is not possible, and ensure alternative criteria are presented as required (s 10(3)(a)).

• Prepare and submit reports on operation and committee views every six months following the date of effect of the declaration (s 31(1)), and arrange an independent assessment of the trial against approved criteria before the Act’s expiry, presenting the assessment and a recommendation that the trial continue for a stated time or cease (s 31(2)).

• When recommending a place, have regard to the cost of setting up and maintaining the facility, capacity to maintain hygiene, ability to meet the objective to provide access to counselling and treatment services, and means of safe disposal of injecting equipment (s 30(a)-(d)).

For prospective operators and staff

• Ensure an operator agreement and internal management protocol anticipate and meet the requirements in s 9(3). Recruit clinical supervisors who are doctors or nurses for any staff who will directly supervise injections (s 9(3)(c)).

• Ensure any staff who will issue injecting equipment hold the Public Health Act part 3A approval (s 9(3)(d)). Obtain that approval before issuing equipment at the facility.

• Implement procedures to offer counselling, rehabilitation or medical services before issuing equipment unless the staff member knows or reasonably believes the person has previously administered a substance (s 15(b)). Put in place records evidencing offers and acceptance/refusal of services.

• Create and maintain secure, hygienic disposal systems and ensure users agree to return equipment for safe disposal (s 15(a)), and establish immediate safe disposal hotspots and protocols in accordance with the internal management protocol.

• Train staff on the Act’s prohibitions (s 14): staff must not sell, possess or use substances at the facility; users must be prohibited from selling or supplying substances in the facility; possession within the facility must not exceed 0.5 g; and users must not possess substances outside the facility.

• Implement exclusion procedures consistent with s 17: the person in charge may exclude orally for stated periods not longer than three days (s 17(1)), or provide written notice with brief reasons (s 17(2)). Ensure exclusion notices and records are maintained and that staff understand the statutory consequence for re‑entry (10 penalty units) should a person contravene exclusion terms (s 17(3)).

Operational, governance and documentation tasks

• Ensure copies of the law enforcement protocol are available for sale and inspection at the places stated in the s 8 public notice and maintain a publicly accessible copy where practicable (s 8(2)-(3)).

• Maintain minutes and records for the advisory committee and ensure the chair or deputy convene meetings as required (s 24-27). Keep administrative arrangements with the director‑general for secretarial services if necessary (s 28).

• Prepare to produce the advisory committee’s six‑monthly reports and the final assessment in time for presentation to the Assembly (s 31). Coordinate with any Minister‑appointed reviewer to facilitate access to data and operational records as permitted by s 16.

• Monitor and be ready to comply with regulations under s 32. Because the criminal exemption in s 11 depends on compliance with “requirements (if any) prescribed under the regulations” (s 11(2)(c)), be proactive in participating in or monitoring regulatory development.

Risk management and legal advice

• Obtain contemporaneous legal advice before relying on s 11 or s 12 protections in particular circumstances. Ensure insurance and contractual arrangements reflect the statutory civil bar and any residual exposures that may remain.

• Plan for the Act’s expiry (s 33) and include termination/transition clauses in contracts with staff, service providers and funders. Ensure data and research arrangements for the independent evaluation are time‑aligned with the statutory reporting obligations (s 31).

This compliance checklist is an operational translation of the Act’s requirements. Because several key elements are contingent on regulations, DPP directions and cross‑statute approvals (for example Public Health Act approvals for syringe supply), those parallel instruments should be identified and integrated into the operator’s compliance matrix as they are issued.